Barbo William D
SEC CIK 1688104 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CRL | Charles River Laboratories | CCO, Corp. Executive VP | 23.3K | — | $7.95M | 34 | 2021-06-09 | 2024-11-07 |
Most active insiders at CRL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | FOSTER JAMES C | Dir | — | $34.84M |
| 2 | Parisotto Shannon M | CEVP, Disc, Safety Assessment | — | $2.97M |
| 3 | Girshick Birgit | COO, Corp. Executive VP | — | $1.82M |
| 4 | Knell Michael Gunnar | SVP, CAO, Fin | — | $1.73M |
| 5 | Creamer Victoria L | EVP, CHRO | — | $1.08M |
| 6 | Andrews Nancy C | Dir | — | $163.4K |
| 7 | LaPlume Joseph W | EVP, Corp Strategy, Develop | $4,364 | — |
| 8 | Mintz Mark | EVP, CIO | — | — |
| 9 | Kemps-Polanco Reshema | Dir | — | — |
| 10 | Barg Steven | Dir | — | — |
Barbo William D made no open-market trades at CRL in the last 12 months.
Transactions 34
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-11-08 | 2024-11-07 | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | G - Gift | $0.00 | -470 | 23.3K | -2% | $0 |
| MA | 2024-05-30 | 2024-05-26+ | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | F - Tax | $217.21 | -423 | 3,711 | -10% | -$91.9K |
| 2024-05-30 | 2024-05-29 | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | F - Tax | $214.51 | -179 | 3,433 | -5% | -$38.4K | |
| M | 2024-05-28 | 2024-05-26+ | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | F - Tax | $217.21 | -393 | 3,605 | -10% | -$85.4K |
| A | 2024-03-25 | 2024-01-29 | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | F - Tax | $220.28 | -744 | 11.3K | -6% | -$163.9K |
| A | 2024-03-25 | 2024-01-29 | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | A - Grant | $0.00 | +2,934 | 12.0K | +32% | $0 |
| I | 2024-02-23 | 2024-02-22 | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | S - Sale | $248.50 | -4,050 | 22.9K | -15% | -$1.01M |
| 2024-01-31 | 2024-01-29 | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | A - Grant | $0.00 | +2,997 | 12.1K | +33% | $0 | |
| 2024-01-31 | 2024-01-29 | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | F - Tax | $220.28 | -770 | 11.3K | -6% | -$169.6K | |
| D | 2023-08-14 | 2023-08-10 | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | M - OptEx | $144.67 | +5,511 | 9,103 | +153% | +$797.3K |
| D | 2023-08-14 | 2023-08-10 | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | S - Sale+OE | $217.24 | -5,763 | 3,592 | -62% | -$1.25M |
| DM | 2023-05-31 | 2023-05-27+ | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | F - Tax | $194.12 | -480 | 10.2K | -5% | -$93.2K |
| D | 2023-05-31 | 2023-05-26 | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | A - Grant | $0.00 | +1,958 | 10.4K | +23% | $0 |
| 2023-02-22 | 2023-02-22 | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | F - Tax | $243.60 | -287 | 8,476 | -3% | -$69.9K | |
| 2023-01-30 | 2023-01-27 | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | A - Grant | $0.00 | +7,857 | 11.7K | +207% | $0 | |
| 2023-01-30 | 2023-01-27 | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | F - Tax | $244.29 | -2,897 | 8,763 | -25% | -$707.7K | |
| D | 2022-12-06 | 2022-06-07 | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | G - Gift | $0.00 | -391 | 3,803 | -9% | $0 |
| DM | 2022-12-06 | 2022-12-02 | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | S - Sale+OE | $219.91 | -3,205 | 6,602 | -33% | -$704.8K |
| DMI | 2022-12-06 | 2022-06-07+ | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | G - Gift | $0.00 | +191 | 19.0K | +1% | $0 |
| D | 2022-12-06 | 2022-12-02 | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | M - OptEx | $109.34 | +3,205 | 7,008 | +84% | +$350.4K |
| DM | 2022-06-01 | 2022-05-28+ | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | F - Tax | $244.41 | -314 | 4,396 | -7% | -$76.7K |
| D | 2022-06-01 | 2022-05-27 | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | A - Grant | $0.00 | +1,493 | 4,508 | +50% | $0 |
| D | 2022-06-01 | 2022-03-11 | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | G - Gift | $0.00 | -754 | 3,015 | -20% | $0 |
| DI | 2022-06-01 | 2022-03-11 | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | G - Gift | $0.00 | +754 | 18.8K | +4% | $0 |
| M | 2022-02-23 | 2022-02-22+ | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | F - Tax | $291.50 | -602 | 4,084 | -13% | -$175.5K |
| 2022-02-23 | 2022-02-08 | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | G - Gift | $0.00 | -6,178 | 4,371 | -59% | $0 | |
| I | 2022-02-23 | 2022-02-08 | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | G - Gift | $0.00 | +6,178 | 18.1K | +52% | $0 |
| 2022-02-01 | 2022-01-28 | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | F - Tax | $312.24 | -4,095 | 10.5K | -28% | -$1.28M | |
| I | 2022-02-01 | 2021-12-01 | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | G - Gift | $0.00 | -400 | 11.9K | -3% | $0 |
| 2022-02-01 | 2022-01-28 | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | A - Grant | $0.00 | +10.3K | 14.6K | +235% | $0 | |
| DM | 2021-08-10 | 2021-08-06 | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | M - OptEx | $136.61 | +7,472 | 12.5K | +149% | +$1.02M |
| DM | 2021-08-10 | 2021-08-06 | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | S - Sale+OE | $402.82 | -12.4K | 13.8K | -47% | -$4.99M |
| DI | 2021-08-10 | 2021-06-09 | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | G - Gift | $0.00 | +252 | 12.3K | +2% | $0 |
| D | 2021-08-10 | 2021-06-09 | CRL | Charles River Laboratories | Barbo William D | CCO, Corp. Executive VP | G - Gift | $0.00 | -252 | 4,371 | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations